🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Exparel and Education to Avoid Opioids After Carpal Tunnel Release

RecruitingPhase 4Ages 18 Years - anyAllKettering Health Network
NCT03867539 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This trial seeks to use the long acting local anesthetic Exparel, in conjunction with opioid education, to attempt to avoid any post-operative opioid use following carpal tunnel surgery. This group will be compared with a "standard" group that receives non-liposomal bupivacaine, opioid education, and opioids.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * carpal tunnel syndrome diagnosed either by physical exam or EMG * age \>18. Exclusion Criteria: * allergy to bupivacaine * pre-operative opioid usage within the last six months * patients allergic to Percocet or acetaminophen * patients taking tricyclic antidepressants (interaction with bupivacaine) * vulnerable populations (prisoners or pregnant women)
💊

What it tests

  • Differing pain management strategy
📍

Where

2 sites
Orthopedic Associates of Southwest Ohio
Dayton, United States
Orthopedic Associates of Southwest Ohio
Dayton, United States
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy